377 results
8-K
EX-99.1
dmt37fsucgdzceq zihs
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
EX-1.1
tq1yg47z01kdj ev
26 Feb 24
Other Events
5:08pm
8-K
EX-4.2
bfe0z 7zhy
26 Feb 24
Other Events
5:08pm
424B5
jfig4 czo
26 Feb 24
Prospectus supplement for primary offering
6:12am
424B5
bm4udn0ppjpvy9slmeyy
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
jmum7iusdvuk
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
i2kx 2r4yeyqxr1a
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
EX-99.1
bj4xxvt1 8ryr
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
nh8ud
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.1
24ktx633z9m
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.2
ht3bu3pozhk9sx
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm